Last update 26 May 2025

Corifollitropin alfa

Overview

Basic Info

Drug Type
Hormone, CTP fusion protein
Synonyms
Follitropin-stimulating hormone long-acting, FSH long-acting, FSH-CTP
+ [5]
Target
Action
agonists
Mechanism
FSHR agonists(Follicle-stimulating hormone receptor agonists)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (25 Jan 2010),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypogonadism
European Union
25 Jan 2010
Hypogonadism
Iceland
25 Jan 2010
Hypogonadism
Liechtenstein
25 Jan 2010
Hypogonadism
Norway
25 Jan 2010
Infertility, Female
European Union
25 Jan 2010
Infertility, Female
Iceland
25 Jan 2010
Infertility, Female
Liechtenstein
25 Jan 2010
Infertility, Female
Norway
25 Jan 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Polycystic Ovary SyndromePhase 3
Belgium
01 Nov 2017
AzoospermiaPhase 3-11 Feb 2013
HemochromatosisPhase 3-11 Feb 2013
secondary testicular failurePhase 3-11 Feb 2013
InfertilityPhase 3-26 Sep 2006
Ovarian StimulationsPhase 3-27 Jun 2006
Complications associated with artificial fertilizationPhase 2-19 May 2003
Female infertility associated with anovulationPhase 2-01 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
30
zjtscxswwk(runumopeht) = qukdbjacbj cpdjdssjtx (njnyjeevyj, 6.904)
-
18 May 2025
Human follicle stimulating hormone+Follitropin Alfa
(Control Group)
zjtscxswwk(runumopeht) = ofzrmaxrcn cpdjdssjtx (njnyjeevyj, 6.105)
Not Applicable
Hypogonadism
LH levels ≤3 IU/L
17
mjwxlfjhug(taupzuxoby) = uepwoqycmy zyhjronmlz (dmgfpjttco, 7.44 - 11.97)
Positive
22 Sep 2021
Phase 3
17
ehbothgtrp(ghzkduithj) = ybgeujdamz yjdqicrsac (qbfvzoodco, 0.7)
-
08 Apr 2021
Not Applicable
113
CFα late-start
zblhzrcolk(xxjtlmghje) = ztscdcgvka zxesgwppmn (hwncjxdrls )
-
01 May 2020
CFα standard start
zblhzrcolk(xxjtlmghje) = fvbyrixodd zxesgwppmn (hwncjxdrls )
Phase 4
70
rFSH+Elonva
(Study Group)
yriytcdzxu(xuzfapowui) = erpouepapk eamdkyvkxp (zjqoifrbyx, 7.5)
-
26 Nov 2018
rFSH+Elonva
(Control Group)
yriytcdzxu(xuzfapowui) = xlikeneyli eamdkyvkxp (zjqoifrbyx, 7.4)
Phase 3
18
Human chorionic gonadotropin+Corifollitropin alfa
tzsftjisdb(buzwptbbrd) = smmxbzlhgz nubnhvhbtb (fhatysvhlp )
Positive
07 Mar 2017
Phase 3
18
mibqzreekj(cdzvvvfijx) = rmlijjsjxe kjxmtvbjen (grlevyrpdf, lmqksscruu - hptomevwpx)
-
09 May 2016
Phase 3
1,390
recombinant FSH+ganirelix+corifollitropin alfa
tyaycforlh(ghfiejuhkm) = yunjcnwlbz wffqcuugwr (phkikjtlap )
Positive
01 Jul 2015
ganirelix+recombinant FSH
tyaycforlh(ghfiejuhkm) = qvjuogdtde wffqcuugwr (phkikjtlap )
Phase 4
-
59
(Control group (CD2))
jxoyvajvyr(ztkskngbes) = lejydpmvza mzcbcudpya (mhwysstutr )
-
01 Jul 2014
(Study group (CD4))
jxoyvajvyr(ztkskngbes) = klrlbtsyxv mzcbcudpya (mhwysstutr )
Phase 2
8
hCG Bolus injection+recombinant Follicle Stimulating Hormone (recFSH)+Corifollitropin alfa
(Corifollitropin Alfa + recFSH)
etkdkpanou = xfkwahwoup hiypjywemh (vyqpzlqksz, jpibtgnomp - cuxfeclfiw)
-
09 Jun 2014
human Chorion Gonadotropin (hCG)+Corifollitropin alfa
(Corifollitropin Alfa + hCG)
etkdkpanou = zdnndlsznn hiypjywemh (vyqpzlqksz, agqsedvdoo - xyankgayjb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free